Agency Information Collection Activities; Submission for Office of Management and Budget Review; Mammography Quality Standards Act Final Regulations; Modifications and Additions to Policy Guidance Help System #9, 77401-77402 [E5-8111]
Download as PDF
wwhite on PROD1PC61 with NOTICES
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
serve as the basis for MHS performance
guarantees. To meet these requirements,
CMS has developed a performance
monitoring system for MHS. This
system includes measures of clinical
performance that require the collection
of clinical data from the medical records
of a sample of Medicare beneficiaries.
Medical record abstraction will be
performed in two phases: The first, a
pilot test, will take place after
approximately six months of program
operations, and the second, the full
study. CMS will obtain active informed
consent from the affected beneficiaries
prior to reviewing medical records;
Frequency: Reporting—Other: Only
Once; Affected Public: Individuals or
Households and Business or other forprofit; Number of Respondents: 26,643;
Total Annual Responses: 26,643; Total
Annual Hours: 12,416.
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare—
Determining Third Party Liability (TPL)
State Plan Preprint and Supporting
Regulations in 42 CFR 433.138; Form
Number: CMS–R–0107 (OMB#: 0938–
0502); Use: Medicaid beneficiaries
frequently have third party resources
which are legally obligated to pay
medical claims before Medicaid pays.
Section 42 CFR 433.138 requires State
Medicaid agencies to take specific steps
to identify third party resources and
determine their legal liability to pay for
services under the plan. The collection
of TPL information results in significant
program savings to the extent that liable
third parties can be identified and
payments can be made for services that
would otherwise be paid for by the
Medicaid program. The State Medicaid
agencies are the primary users of the
collected data. Whenever States identify
third party resources, pertinent
information is entered into the State’s
Medicaid Management Information
System (MMIS). This enables the State
to advise the provider to bill the third
party and to seek reimbursement in
situations where Medicaid TPL claims
have been paid; Frequency:
Recordkeeping—On occasion; Affected
Public: Individuals or Households and
Federal, State, Local and Tribal
Government; Number of Respondents:
2,700,000; Total Annual Responses:
2,700,000; Total Annual Hours: 472,259.
4. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Request for
Retirement Benefit Information (BBA
’97); Form Number: CMS–R–285
(OMB#: 0938–0769); Use: The Request
for Retirement Benefit Information form
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
is used to obtain retirement benefit
information from beneficiaries that
purchase Medicare Part A coverage. The
Social Security Administration (SSA)
will use this information to determine if
a beneficiary meets the requirements to
qualify for a Medicare Part A premium
reduction; Frequency: Reporting—On
occasion; Affected Public: State, Local
or Tribal Government; Number of
Respondents: 1500; Total Annual
Responses: 1500; Total Annual Hours:
375.
To obtain copies of the supporting
statement and any related forms for
these paperwork collections referenced
above, access CMS Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office at (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB Desk Officer at
the address below, no later than 5 p.m.
on January 30, 2006.
OMB Human Resources and Housing
Branch, Attention: Carolyn Lovett,
CMS Desk Officer, New Executive
Office Building, Room 10235,
Washington, DC 20503.
Dated: December 21, 2005.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. 05–24567 Filed 12–29–05; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N–0216]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Medical Devices; Humanitarian Use
Devices
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Medical Devices; Humanitarian Use
Devices’’ has been approved by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
77401
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–4659.
SUPPLEMENTARY INFORMATION: In the
Federal Register of October 24, 2005 (70
FR 61455), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0332. The
approval expires on December 31, 2008.
A copy of the supporting statement for
this information collection is available
on the Internet at https://www.fda.gov/
ohrms/dockets.
Dated: December 22, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E5–8110 Filed 12–29–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005D–0195]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Mammography Quality Standards Act
Final Regulations; Modifications and
Additions to Policy Guidance Help
System #9
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by January 30,
2006.
ADDRESSES: The Office of Management
and Budget (OMB) is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that comments be
faxed to the Office of Information and
Regulatory Affairs, OMB, Attn: Fumie
E:\FR\FM\30DEN1.SGM
30DEN1
77402
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
Yokota, Desk Officer for FDA, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–1472.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Mammography Quality Standards Act
Final Regulations; Modifications and
Additions to Policy Guidance Help
System #9
The Mammography Quality Standards
Act (MQSA) Final Regulations:
Modifications and Additions to Policy
Guidance Help System 9 provides
guidance to mammography facilities
and their personnel on a variety of
issues involving the quality standards
for mammography (§ 900.12 (21 CFR
900.12)). Use of the guidance results in
new collections of information.
Facilities are required to provide
patients with lay summaries of the
results of their mammography
examinations (§ 900.12(c)(2)). This
guidance document provides
information on how to address a
patient’s refusal to receive a lay
summary and recommends that the
facility document why it was unable to
meet this requirement. Additionally, the
guidance addresses interpreting
physician initial requirements
(§ 900.12(a)(1)(i)(B)(2)), including
recommendations on how to document
the alternative to Board Certification for
foreign-trained physicians.
The likely respondents are
mammography facilities and their
personnel who are subject to the MQSA
quality standards requirements.
In the Federal Register of July 15,
2005 (70 FR 41043), FDA published a
60-day notice requesting comments on
the information collection provisions.
No comments were received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
Activity
Number of Respondents
Annual Frequency of
Response
915
1
Reporting of refusal of lay summary
1There
Total Annual Responses
Hours per Response
915
Total Hours
0.5
458
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
Activity
Number of Recordkeepers
Documentation of foreign-trained
physicians’ qualifications
1There
Total Annual Records
Hours Per Record
1
92
8
92
Total hours
736
are no capital costs or operating and maintenance costs associated with this collection of information.
There are a total of 9,150 MQSAcertified facilities. Using past
experience, FDA estimates that 10
percent of these facilities will receive
patient requests that lay summary
results not be sent. We also estimate that
the facility will spend 0.5 hours per
patient obtaining the patient’s written
request, filing that form in the patient’s
record and forwarding the summary to
the patient’s designee. With respect to
foreign-trained physicians, past
experience indicates that this situation
arises very infrequently. We estimate
that only 1 percent of MQSA-certified
facilities will have to maintain records
documenting the qualifications of
foreign-trained physicians.
Dated: December 22, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E5–8111 Filed 12–29–05; 8:45 am]
BILLING CODE 4160–01–S
wwhite on PROD1PC61 with NOTICES
Annual Frequency per
Record
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N–0217]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Cosmetic Product Voluntary Reporting
Program
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Cosmetic Product Voluntary Reporting
Program’’ has been approved by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–4659.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
In the
Federal Register of October 11, 2005 (70
FR 59073), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0030. The
approval expires on December 31, 2008.
A copy of the supporting statement for
this information collection is available
on the Internet at https://www.fda.gov/
ohrms/dockets.
SUPPLEMENTARY INFORMATION:
Dated: December 22, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E5–8112 Filed 12–29–05; 8:45 am]
BILLING CODE 4160–01–S
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 70, Number 250 (Friday, December 30, 2005)]
[Notices]
[Pages 77401-77402]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-8111]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005D-0195]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Mammography Quality Standards Act
Final Regulations; Modifications and Additions to Policy Guidance Help
System 9
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by January
30, 2006.
ADDRESSES: The Office of Management and Budget (OMB) is still
experiencing significant delays in the regular mail, including first
class and express mail, and messenger deliveries are not being
accepted. To ensure that comments on the information collection are
received, OMB recommends that comments be faxed to the Office of
Information and Regulatory Affairs, OMB, Attn: Fumie
[[Page 77402]]
Yokota, Desk Officer for FDA, FAX: 202-395-6974.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Management
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-1472.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Mammography Quality Standards Act Final Regulations; Modifications and
Additions to Policy Guidance Help System 9
The Mammography Quality Standards Act (MQSA) Final Regulations:
Modifications and Additions to Policy Guidance Help System 9 provides
guidance to mammography facilities and their personnel on a variety of
issues involving the quality standards for mammography (Sec. 900.12
(21 CFR 900.12)). Use of the guidance results in new collections of
information. Facilities are required to provide patients with lay
summaries of the results of their mammography examinations (Sec.
900.12(c)(2)). This guidance document provides information on how to
address a patient's refusal to receive a lay summary and recommends
that the facility document why it was unable to meet this requirement.
Additionally, the guidance addresses interpreting physician initial
requirements (Sec. 900.12(a)(1)(i)(B)(2)), including recommendations
on how to document the alternative to Board Certification for foreign-
trained physicians.
The likely respondents are mammography facilities and their
personnel who are subject to the MQSA quality standards requirements.
In the Federal Register of July 15, 2005 (70 FR 41043), FDA
published a 60-day notice requesting comments on the information
collection provisions. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
Number of Annual Frequency of Total Annual Hours per
Activity Respondents Response Responses Response Total Hours
----------------------------------------------------------------------------------------------------------------
Reporting 915 1 915 0.5 458
of refusal
of lay
summary
----------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2.--Estimated Annual Recordkeeping Burden\1\
----------------------------------------------------------------------------------------------------------------
Number of Annual Frequency per
Activity Recordkeepers Record Total Annual Records Hours Per Record Total hours
----------------------------------------------------------------------------------------------------------------
Documentati 92 1 92 8 736
on of
foreign-
trained
physicians
'
qualificat
ions
----------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
There are a total of 9,150 MQSA-certified facilities. Using past
experience, FDA estimates that 10 percent of these facilities will
receive patient requests that lay summary results not be sent. We also
estimate that the facility will spend 0.5 hours per patient obtaining
the patient's written request, filing that form in the patient's record
and forwarding the summary to the patient's designee. With respect to
foreign-trained physicians, past experience indicates that this
situation arises very infrequently. We estimate that only 1 percent of
MQSA-certified facilities will have to maintain records documenting the
qualifications of foreign-trained physicians.
Dated: December 22, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E5-8111 Filed 12-29-05; 8:45 am]
BILLING CODE 4160-01-S